Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BridgeBio Pharma (BBIO) Current Taxes (2024 - 2025)

Historic Current Taxes for BridgeBio Pharma (BBIO) over the last 2 years, with Q2 2025 value amounting to $2.1 million.

  • BridgeBio Pharma's Current Taxes changed N/A to $2.1 million in Q2 2025 from the same period last year, while for Jun 2025 it was $2.1 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2024, which is N/A changed from last year.
  • Per BridgeBio Pharma's latest filing, its Current Taxes stood at $2.1 million for Q2 2025.
  • Over the past 5 years, BridgeBio Pharma's Current Taxes peaked at $2.1 million during Q2 2025, and registered a low of $1.2 million during Q4 2024.